News Conference News AHA 2023 ARTESiA: Apixaban Lowers Stroke Risk in Subclinical AF Todd Neale November 12, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Conference News ESC 2023 ESC Issues New ACS Guidelines: Directions on Invasive Timing, DAPT, and More Michael O'Riordan September 06, 2023
News Conference News ESC 2023 ONCO DVT Supports 12 Months of Preventive DOACs in Cancer Patients L.A. McKeown August 30, 2023
News Conference News ESC 2023 FRAIL-AF: Warfarin Beats NOACs in Frail Elderly With AF Shelley Wood August 28, 2023
News Conference News ESC 2023 NOAH-AFNET 6: Edoxaban for Atrial High-Rate Episodes: No Help, Some Harm Todd Neale August 25, 2023
News Conference News ESOC 2023 ECST-2: No Benefit of Carotid Revascularization on Top of Best Medical Therapy Todd Neale May 26, 2023
News Conference News ESOC 2023 ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy Todd Neale May 25, 2023
News Conference News ESOC 2023 ELAN: Early DOACs Safe, May Help After Ischemic Stroke in AF Patients Todd Neale May 24, 2023
News Conference News EuroPCR 2023 AnchorMan LAAO Device Matches Up Well With the Watchman Todd Neale May 19, 2023
News Conference News EuroPCR 2023 ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure Todd Neale May 18, 2023
News Conference News ISC 2023 Does All AF After Stroke Warrant Anticoagulation? Experts Debate Todd Neale February 17, 2023
News Conference News ISET 2023 BEST-CLI: Experts at ISET Look to Bridge Research Results and Practice Caitlin E. Cox January 25, 2023
News Conference News ISET 2023 The PE Pipeline: Evidence Trickles in for Catheter-Based Therapies Caitlin E. Cox January 23, 2023